AbbVie’s late-stage experimental drug reduces menstrual migraine days
HQ Team September 11, 2026: AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key.
Drugs
Medical
Pharma
Drugs
Health
Medical
Preoperative botox jabs may help identify migraine trigger sites
HQ Team May 10, 2024: Botox has been traditionally used to treat migraine, but there is not enough data available to prove its.
Drugs
Health
Pharma
Pfizer enters Hong Kong migraine market, its first in Asia
HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.